If you made any changes in Pure these will be visible here soon.

Research Output 1997 2019

Filter
Review article
2018
Peptide Receptors
Radioisotopes
Neoplasms
Therapeutics
Neuroendocrine Tumors
2017

Individualized dosimetry for theranostics: Necessary, nice to have, or counterproductive?

Eberlein, U., Cremonesi, M. & Lassmann, M., Sep 1 2017, In : Journal of Nuclear Medicine. 58, p. 97S-103S

Research output: Contribution to journalReview article

Radiotherapy
Therapeutics
Radiation Oncology
Peptide Receptors
Nuclear Medicine
Fluorodeoxyglucose F18
Chemoradiotherapy
Rectal Neoplasms
Uterine Cervical Neoplasms
Neoplasms
Fluorodeoxyglucose F18
Head and Neck Neoplasms
Positron-Emission Tomography
therapy
positrons
Fluorodeoxyglucose F18
Esophageal Neoplasms
Positron-Emission Tomography
Radiotherapy
Therapeutic Uses
Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Positron-Emission Tomography
Radiotherapy
Neoplasms
2016

Myeloid neoplasms after chemotherapy and PRRT: Myth and reality

Bodei, L., Modlin, I. M., Luster, M., Forrer, F., Cremonesi, M., Hicks, R. J., Ezziddin, S., Kidd, M. & Chiti, A., 2016, In : Endocrine-Related Cancer. 23, 8, p. C1-C7

Research output: Contribution to journalReview article

Reality Therapy
Peptide Receptors
Radioisotopes
Drug Therapy
Neuroendocrine Tumors

Myeloid neoplasms after chemotherapy and PRRT: Myth and reality

Bodei, L., Modlin, I. M., Luster, M., Forrer, F., Cremonesi, M., Hicks, R. J., Ezziddin, S., Kidd, M. & Chiti, A., 2016, In : Endocrine-Related Cancer. 23, 8, p. C1-C7

Research output: Contribution to journalReview article

Reality Therapy
Peptide Receptors
Radioisotopes
Drug Therapy
Neuroendocrine Tumors